Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A McKinsey

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Journal of Molecular and Cellular Cardiology|November 27, 2010
Isoform-selective HDAC inhibitors: closing in on translational medicine for the heartTimothy A McKinsey
Annual Review of Pharmacology and Toxicology|September 28, 2011
Therapeutic potential for HDAC inhibitors in the heartTimothy A McKinsey
Molecular Medicine (Cambridge, Mass.)|January 27, 2011
Targeting inflammation in heart failure with histone deacetylase inhibitorsTimothy A McKinsey
Cardiovascular Research|January 16, 2007
Derepression of pathological cardiac genes by members of the CaM kinase superfamilyTimothy A McKinsey
Handbook of Experimental Pharmacology|September 1, 2011
The biology and therapeutic implications of HDACs in the heartTimothy A McKinsey
Journal of Molecular and Cellular Cardiology|February 16, 2016
Epigenetic regulation of cardiac fibrosisMatthew S Stratton, Timothy A McKinsey
Trends in Genetics : TIG|March 26, 2004
Cardiac histone acetylation--therapeutic opportunities aboundTimothy A McKinsey, Eric N Olson
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 25, 2015
Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophyMatthew S Stratton, Timothy A McKinsey
Nature Metabolism|July 23, 2020
ABHD5 cleaves HDAC4 to benefit the heartJoshua G Travers, Timothy A McKinsey
Journal of Molecular and Cellular Cardiology|May 20, 2014
BET-ting on chromatin-based therapeutics for heart failureSaptarsi M Haldar, Timothy A McKinsey
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Journal of Molecular and Cellular Cardiology|November 27, 2010
Isoform-selective HDAC inhibitors: closing in on translational medicine for the heartTimothy A McKinsey
Annual Review of Pharmacology and Toxicology|September 28, 2011
Therapeutic potential for HDAC inhibitors in the heartTimothy A McKinsey
Molecular Medicine (Cambridge, Mass.)|January 27, 2011
Targeting inflammation in heart failure with histone deacetylase inhibitorsTimothy A McKinsey
Cardiovascular Research|January 16, 2007
Derepression of pathological cardiac genes by members of the CaM kinase superfamilyTimothy A McKinsey
Handbook of Experimental Pharmacology|September 1, 2011
The biology and therapeutic implications of HDACs in the heartTimothy A McKinsey
Journal of Molecular and Cellular Cardiology|February 16, 2016
Epigenetic regulation of cardiac fibrosisMatthew S Stratton, Timothy A McKinsey
Trends in Genetics : TIG|March 26, 2004
Cardiac histone acetylation--therapeutic opportunities aboundTimothy A McKinsey, Eric N Olson
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 25, 2015
Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophyMatthew S Stratton, Timothy A McKinsey
Nature Metabolism|July 23, 2020
ABHD5 cleaves HDAC4 to benefit the heartJoshua G Travers, Timothy A McKinsey
Journal of Molecular and Cellular Cardiology|May 20, 2014
BET-ting on chromatin-based therapeutics for heart failureSaptarsi M Haldar, Timothy A McKinsey
Pageof 18